EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Glycemic Targets and Prevention of Complications

Yumiko Tsushima iD, Nicholas Galloway iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae776 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Yumiko Tsushima und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University Hospitals Cleveland Medical Center, Diabetes and Metabolic Care Center, Cleveland, OH 44106, USA. Hauptthemen laut MEDLINE: Diabetes Complications. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 90 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Complications of diabetes mellitus have significant impacts on morbidity, mortality, quality of life, and health costs for individuals. Setting and achieving glycemic targets to prevent these complications is a top priority when managing diabetes. However, patients often already have complications when diagnosed with diabetes mellitus. Therefore, methods to prevent disease progression become a crucial component of diabetes management. The purpose of this article is to review glycemic targets and methods of screening and managing diabetes-related complications. Evidence Acquisition A PubMed review of the literature pertaining to diabetes mellitus, glycemic targets, microvascular complications, and macrovascular complications was conducted. We reviewed articles published between 1993 and 2024. Guidelines published by nationally recognized organizations in the fields of diabetes, nephrology, and cardiology were referenced. Public health statistics obtained by the Center for Disease Control and Prevention and the National Kidney Foundation were used. Evidence Synthesis Achieving glycemic targets and screening for diabetes-related complications at appropriate intervals remains the key factor for early detection and intervention. An algorithmic approach to glycemic management based on individual risk factors is beneficial in choosing pharmacotherapy.

Conclusion

The consequences of diabetes-related complications can be detrimental. However, achieving and maintaining glycemic targets combined with diligent screening, reduction of risk factors, and prompt treatment can halt disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes ComplicationsHumansGlycemic ControlMetabolic SyndromeDiabetic NephropathiesDiabetic RetinopathyNervous System DiseasesNon-alcoholic Fatty Liver DiseaseGlycated Hemoglobin

Stichwörter der Autor:innen

CKM syndromeMASLDchronic kidney diseaseglycemic targetneuropathyretinopathy

Substanzen

hemoglobin A1c protein, humanGlycated Hemoglobin

Autor:innen und Institutionen

  • Department of Internal Medicine, University Hospitals Cleveland Medical Center, Diabetes and Metabolic Care Center, Cleveland, OH 44106, USA.

ORCID-Profile: Yumiko Tsushima, Nicholas Galloway

Zitieren

APA

Tsushima, Y., & Galloway, N. (2025). Glycemic Targets and Prevention of Complications. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae776

Vancouver

Tsushima Y, Galloway N. Glycemic Targets and Prevention of Complications. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae776

BibTeX
@article{Tsushima2025,
  author = {Tsushima, Yumiko and Galloway, Nicholas},
  title = {Glycemic Targets and Prevention of Complications},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae776}
}
Kostenlos starten →